RECENT PLACEMENT

Occam Places Lisa Deschamps as CEO of AviadoBio

Occam Places Lisa Deschamps as CEO of AviadoBio

Occam recently recruited Lisa Deschamps to AviadoBio. She takes the helm of this neuro gene therapy company based on the scientific research of Chris Shaw of King’s College London after having had a distinguished career at Novartis in a variety of senior executive management positions in neuroscience and gene therapy. In addition to bringing deep content knowledge to Aviado, Lisa has also provided leadership for the company’s recently successful $80 million financing, bringing in new investors including NEA.

‍

Recent Placements

  1. Bastiano Sanna as CEO of Semma
  2. Bill Brondyk as CSO at Invetx
  3. Aron Feingold as VP of Investor Relations & Corporate Communications at Geron
  4. Brian Goldman as Chief Computation Officer at ZebiAI
  5. Ann Taylor as Board Member at Comanche Biopharma
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.